Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Breast Neoplasms: HELP
Luke Hughes-Davies
Based on 12 articles published since 2009
(Why 12 articles?)
||||
Expertise Level
The expertise of Luke Hughes-Davies ranks in the
  • Top 1.3%
  • ... of 265,285 published authors worldwide on Breast Neoplasms
  • ... from 2009 through 2019
  • ... based on contributions to 12 articles on the topic.
Graphical view (beta)
Aliases Hughes-Davies, L   ·   Hughes-Davies, Luke
Work Locations
Details
Most likely:    University of Cambridge      
2019
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; Department of Oncology, North West Anglia NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, James Paget University Hospital, Norfolk, UK; Department of Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS, Brighton, UK. · Cancer Research UK Clinical Trials Unit and Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Department of Oncology, Southampton University Hospital NHS Foundation Trust, Southampton, UK. · Department of Oncology, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Independent Cancer Patients Voice, London, UK. · Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK. · Oncology Global Drug Development, Novartis, Basel, Switzerland. · Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Pharmacy, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Institute of Health Economics, Edmonton, Canada. · Academic Unit of Health Economics, University of Leeds, Leeds, UK; Health Economics Group, Institute of Health Research, University of Exeter Medical School, Exeter, UK. · Research & Development, The NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, ManchesterAcademic Health Science Centre, University of Manchester, Manchester, UK. · Pubmed 31178152
2017
  • Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. Electronic address: · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Independent Cancer Patients' Voice, London, UK. · National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. · University of Alberta, Edmonton, Alberta, Canada. · Pubmed 29241890
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
  • Division of Cancer Studies, King's College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry CV4 7AL, UK. · Ontario Institute of Cancer Research, Toronto, Ontario M5G 0A3, Canada. · UCL-Advanced Diagnostics, University College London, 21 University Street, London WC1E 6JJ, UK. · Department of Pathology, University College London Hospitals, 235, Euston Road, London NW1 2BU, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, HA6 2RN, UK. · Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Oncology, University College London Hospitals, London NW1 2PG, UK. · Pubmed 28222072
2016
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB) · University of Toronto, Toronto, Canada (JMSB) · University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC) · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC) · University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP) · University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME) · Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR) · University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC) · University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF) · University of Alberta, Edmonton, AB, Canada (CM) · Kings College London, Guy's Hospital, London, UK (SEP) · Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD) · Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM) · National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Pubmed 27130929
  • Department of Oncology, University College London Hospitals, London, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, ON, Canada. · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Independent Cancer Patients' Voice, London, UK. · Research Oncology, Division of Cancer Studies, King's College London, London, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada. · Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundations Trust, Cambridge, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, UK. · Pubmed 26867046
2015
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
2014
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. Electronic address: · Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, UK. · University of Melbourne, Shepparton, VIC, Australia. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · CancerResearch UK Cambridge Institute, Cambridge, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Department of Surgery, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Nottingham City Hospital, Hucknall Road, Nottingham, UK. · Dorset Cancer Centre, Poole Hospital NHS Trust, Poole, UK. · Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, UK. · Breast Oncology Unit, Thomas Guy House, Guys Hospital, St Thomas Street, London, UK. · Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · Pubmed 24360787
Possible:    Ontario Institute for Cancer Research      
2013
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 23267818
Possible:    University of Washington   Contact    
2011
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 12 total) written by Luke Hughes-Davies about Breast Neoplasms:

  • 6 versus 12 months of adjuvant trastuzumab for HER2-positive early breast cancer (PERSEPHONE): 4-year disease-free survival results of a randomised phase 3 non-inferiority trial. 2019
  • Value of Information Analysis of Multiparameter Tests for Chemotherapy in Early Breast Cancer: The OPTIMA Prelim Trial. 2017
  • Central pathology review with two-stage quality assurance for pathological response after neoadjuvant chemotherapy in the ARTemis Trial. 2017
  • Disease-free and overall survival at 3.5 years for neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin and cyclophosphamide, for women with HER2 negative early breast cancer: ARTemis Trial. 2017
  • Discrepancies in central review re-testing of patients with ER-positive and HER2-negative breast cancer in the OPTIMA prelim randomised clinical trial. 2017
  • Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others. 2016
  • OPTIMA prelim: a randomised feasibility study of personalised care in the treatment of women with early breast cancer. 2016
  • Efficacy of neoadjuvant bevacizumab added to docetaxel followed by fluorouracil, epirubicin, and cyclophosphamide, for women with HER2-negative early breast cancer (ARTemis): an open-label, randomised, phase 3 trial. 2015
  • Effects of the addition of gemcitabine, and paclitaxel-first sequencing, in neoadjuvant sequential epirubicin, cyclophosphamide, and paclitaxel for women with high-risk early breast cancer (Neo-tAnGo): an open-label, 2×2 factorial randomised phase 3 trial. 2014
  • Selecting breast cancer patients for chemotherapy: the opening of the UK OPTIMA trial. 2013
Show List of Full Article Records
Google Searches

Learn more about Luke Hughes-Davies using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
University of Cambridge
Ontario Institute for Cancer Research
University of Washington
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
University of Cambridge
2019
  • Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; Department of Oncology, North West Anglia NHS Foundation Trust, Peterborough City Hospital, Peterborough, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Oncology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, James Paget University Hospital, Norfolk, UK; Department of Oncology, Norfolk & Norwich University Hospital, Norwich, UK. · Medical Oncology, Mount Vernon Cancer Centre, Northwood, UK. · Sussex Cancer Centre, Brighton and Sussex University Hospitals NHS, Brighton, UK. · Cancer Research UK Clinical Trials Unit and Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Department of Oncology, Southampton University Hospital NHS Foundation Trust, Southampton, UK. · Department of Oncology, Royal Derby Hospital, Derby, UK. · Department of Medical Oncology, Guy's and St Thomas' NHS Foundation Trust, London, UK. · Independent Cancer Patients Voice, London, UK. · Department of Cardiology, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK; Freeman Hospital, Newcastle upon Tyne, UK. · Oncology Global Drug Development, Novartis, Basel, Switzerland. · Metabolic Research Laboratories, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Histopathology, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Pharmacy, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK. · Department of Oncology, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Cancer Research Unit, Cambridge University Hospitals National Health Service (NHS) Foundation Trust, Cambridge, UK; National Institute for Health Research Cambridge Biomedical Research Centre, Cambridge, UK; Cancer Research UK Cambridge Institute, University of Cambridge Li Ka Shing Centre, Cambridge, UK. · Cancer Edinburgh Research Centre, The Institute of Genetics and Molecular Medicine, University of Edinburgh, Western General Hospital, Edinburgh, UK. · Institute of Health Economics, Edmonton, Canada. · Academic Unit of Health Economics, University of Leeds, Leeds, UK; Health Economics Group, Institute of Health Research, University of Exeter Medical School, Exeter, UK. · Research & Development, The NIHR Manchester Clinical Research Facility at The Christie NHS Foundation Trust, Manchester, UK; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, ManchesterAcademic Health Science Centre, University of Manchester, Manchester, UK. · Pubmed 31178152
2017
  • Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK; Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. Electronic address: · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Northwood, UK. · Department of Oncology, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK. · Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Independent Cancer Patients' Voice, London, UK. · National Institute for Health Research, University College London Hospitals Biomedical Research Centre, London, UK. · University of Alberta, Edmonton, Alberta, Canada. · Pubmed 29241890
  • Department of Pathology, Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, Addenbrookes Hospital, Cambridge, UK. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Histopathology, Addenbrookes Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · The Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Poole Hospital NHS Foundation Trust, Poole, UK. · Bournemouth University, Poole, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · Institute for Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK. · Cancer Research UK Cambridge Institute, University of Cambridge, Li Ka Shing Centre, Cambridge, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, ON, Canada. · University of Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Department of Medical Oncology, NHS Lothian, Western General Hospital, Edinburgh, UK. · Pubmed 28548129
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
  • Division of Cancer Studies, King's College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Campus, Coventry CV4 7AL, UK. · Ontario Institute of Cancer Research, Toronto, Ontario M5G 0A3, Canada. · UCL-Advanced Diagnostics, University College London, 21 University Street, London WC1E 6JJ, UK. · Department of Pathology, University College London Hospitals, 235, Euston Road, London NW1 2BU, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, HA6 2RN, UK. · Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Department of Oncology, University College London Hospitals, London NW1 2PG, UK. · Pubmed 28222072
2016
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB, JB) · University of Toronto, Toronto, Canada (JMSB) · University of Edinburgh, Edinburgh, UK (JMSB, CC, MSS, PSH, DAC) · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK (AM, JAD, AC) · University Hospitals Coventry and Warwickshire NHS Trust, Coventry, UK (CJP) · University of Cambridge Department of Oncology and NIHR Cambridge Biomedical Research Centre, Cambridge, UK (HME) · Cancer Research UK Institute for Cancer Studies, University of Birmingham, Birmingham, UK (DWR) · University of Glasgow, Beatson West of Scotland Cancer Centre, Glasgow, UK (IRM, PC) · University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK (AF) · University of Alberta, Edmonton, AB, Canada (CM) · Kings College London, Guy's Hospital, London, UK (SEP) · Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK (LHD) · Mount Vernon Cancer Centre, East and North Hertfordshire NHS Trust, Middlesex, UK (AM) · National Institute for Health Research University College London Hospitals Biomedical Research Centre, London, UK (RCS). · Pubmed 27130929
  • Department of Oncology, University College London Hospitals, London, UK. · Warwick Medical School, University of Warwick, Coventry, UK. · Ontario Institute for Cancer Research, Toronto, ON, Canada. · Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, UK. · School of Social and Community Medicine, University of Bristol, Bristol, UK. · Independent Cancer Patients' Voice, London, UK. · Research Oncology, Division of Cancer Studies, King's College London, London, UK. · Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK. · Department of Emergency Medicine, University of Alberta, Edmonton, AB, Canada. · Oncology Centre, Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundations Trust, Cambridge, UK. · Department of Clinical Oncology, Mount Vernon Cancer Centre, Mount Vernon Hospital, Northwood, UK. · Pubmed 26867046
2015
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK. Electronic address: · Warwick Clinical Trials Unit, University of Warwick, Coventry, UK. · Cambridge Clinical Trials Unit-Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Western General Hospital, Edinburgh, UK. · NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK. · Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Peterborough City Hospital, Edith Cavell Campus, Peterborough, UK. · Nottingham University Hospital (City Campus), Nottingham, UK. · West Middlesex University Hospital, Isleworth, UK. · Royal Bournemouth Hospital, Bournemouth University, Bournemouth, UK. · The Royal Surrey County Hospital NHS Foundation Trust, Guildford, UK. · City Hospital, Dudley Road, Birmingham, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario, Canada; Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Cambridge, UK; NIHR Cambridge Biomedical Research Centre, and Cambridge Breast Cancer Research Unit Cambridge, Cambridge, UK; Cancer Research UK Cambridge Institute, Cambridge, UK. · Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, UK. · Pubmed 25975632
2014
  • University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. Electronic address: · Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. Electronic address: · Cancer Research UK Clinical Trials Unit, Institute for Cancer Studies, University of Birmingham, Edgbaston, Birmingham, UK. · University of Melbourne, Shepparton, VIC, Australia. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · CancerResearch UK Cambridge Institute, Cambridge, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; Peterborough and Stamford Hospitals NHS Foundation Trust and Cambridge University Hospital NHS Foundation Trust, UK. · Royal Surrey County Hospital NHS Foundation Trust, Egerton Road, Guildford, UK. · Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Department of Surgery, Royal Bournemouth Hospital, Castle Lane East, Bournemouth, UK. · Nottingham City Hospital, Hucknall Road, Nottingham, UK. · Dorset Cancer Centre, Poole Hospital NHS Trust, Poole, UK. · Beatson West of Scotland Cancer Centre, 1053 Great Western Road, Glasgow, UK. · Breast Oncology Unit, Thomas Guy House, Guys Hospital, St Thomas Street, London, UK. · Department of Medical Oncology, St Bartholomew's Hospital, West Smithfield, London, UK. · Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · Warwick Clinical Trials Unit, University of Warwick, Gibbet Hill Road, Coventry, UK. · National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK. · University of Cambridge, Department of Oncology, Addenbrooke's Hospital, Hills Road, Cambridge, UK; National Institute for Health Research, Cambridge Biomedical Research Centre and Cambridge Experimental Cancer Medicine Centre, Hills Road, Cambridge, UK; Department of Oncology, Cambridge Cancer Trials Centre, Addenbrooke's Hospital, Cambridge, UK; Cambridge Breast Unit and Cambridge University Hospitals NHS Foundation Trust, Hills Road, Cambridge, UK; CancerResearch UK Cambridge Institute, Cambridge, UK. · Pubmed 24360787
Unspecified
2017
  • Department of Oncology, University of Cambridge, Cambridge. · NIHR Cambridge Biomedical Research Centre, Cambridge. · Cambridge Breast Cancer Research Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Warwick Clinical Trials Unit, University of Warwick, Coventry. · Cambridge Clinical Trials Unit - Cancer Theme, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Queen Elizabeth Hospital King's Lynn NHS Foundation Trust, King's Lynn. · Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge. · Department of Oncology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Oncology, Peterborough and Stamford Hospitals NHS Foundation Trust, Peterborough. · Department of Oncology, Nottingham City Hospital, Nottingham. · Department of Oncology, West Middlesex University Hospital, Isleworth. · Department of Oncology, Poole Hospital NHS Foundation Trust/Bournemouth University, Poole. · Cancer Research UK Clinical Trials Unit, University of Birmingham, Edgbaston, UK. · Ontario Institute for Cancer Research, MaRS Centre, Toronto, Canada. · Cancer Research Centre, University of Edinburgh, IGMM, Western General Hospital, Edinburgh. · Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge. · Department of Pathology, University of Edinburgh, Edinburgh, UK. · Pubmed 28459938
Ontario Institute for Cancer Research
2013
  • Ontario Institute for Cancer Research, Toronto, Ontario, Canada. · Pubmed 23267818
University of Washington
2011
Yearly article counts 10421111100
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.